Back
Materion Corp. 10K Form
Buy
80
MTRN
Materion Corp.
Last Price:
$133.79
Seasonality Move:
8.54%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | MTRN/Materion Corp. Quarterly |
| 2024-02-15 | 10K | MTRN/Materion Corp. Annual |
| 2023-11-01 | 10Q | MTRN/Materion Corp. Quarterly |
| 2023-08-02 | 10Q | MTRN/Materion Corp. Quarterly |
| 2023-05-03 | 10Q | MTRN/Materion Corp. Quarterly |
| 2023-02-16 | 10K | MTRN/Materion Corp. Annual |
Receive MTRN News And Ratings
See the #1 stock for the next 7 days that we like better than MTRN
MTRN Financial Statistics
Sales & Book Value
| Annual Sales: | $1.7B |
|---|---|
| Cash Flow: | $-5.3M |
| Price / Cash Flow: | 39.59 |
| Annual Sales: | $45.08 |
| Price / Book: | 3.3 |
Profitability
| EPS (TTM): | 0.91660 |
|---|---|
| Net Income (TTM): | $19.4M |
| Gross Margin: | $313.2M |
| Return on Equity: | 2.14% |
| Return on Assets: | 1.1% |
Materion Corp. Earnings Forecast
Key Materion Corp. Financial Ratios
-
The Gross Profit Margin over the past 45 years for MTRN is 18.59%.
-
The Selling, General & Administrative Expenses for MTRN have been equal to 8.64% of Gross Profit Margin.
-
The Research & Development expenses have been 1.72% of Revenue.
-
The Interest Expense is 507.44% of Operating Income.
-
The Net Earning history of MTRN is 0.35% of Total Revenues.
-
Per Share Earnings over the last 45 years have been positive in 21 years.
Materion Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Metals & Mining |
| Sector: | Materials |
| Current Symbol: | MTRN |
| CUSIP: | 576690 |
| Website: | materion.com |
Debt
| Debt-to-Equity Ratio: | 0.57 |
|---|---|
| Current Ratio: | 3.29 |
| Quick Ratio: | 0.9 |
Price-to-Earnings
| Trailing P/E Ratio: | 528.71 |
|---|---|
| Forward P/E Ratio: | 19.56 |
MTRN Technical Analysis vs Fundamental Analysis
Buy
80
Materion Corp. (MTRN)
is a Buy
Is Materion Corp. a Buy or a Sell?
-
Materion Corp. stock is rated a BuyThe current Materion Corp. [MTRN] share price is $148.78. The Score for MTRN is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.